Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19


Growth and descent of the testes in infants with hypogonadotropic hypogonadism receiving subcutaneous gonadotropin infusion.

Lambert AS, Bougneres P.

Int J Pediatr Endocrinol. 2016;2016:13. doi: 10.1186/s13633-016-0031-9.


Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use.

McBride JA, Coward RM.

Asian J Androl. 2016 May-Jun;18(3):373-80. doi: 10.4103/1008-682X.173938. Review.


Medical treatment of male infertility.

Dabaja AA, Schlegel PN.

Transl Androl Urol. 2014 Mar;3(1):9-16. doi: 10.3978/j.issn.2223-4683.2014.01.06. Review.


Mini puberty and its interpretation.

Kurtoğlu S, Baştuğ O.

Turk Pediatri Ars. 2014 Sep 1;49(3):186-91. doi: 10.5152/tpa.2014.2038. Review.


Psychosexual development in men with congenital hypogonadotropic hypogonadism on long-term treatment: a mixed methods study.

Dwyer AA, Quinton R, Pitteloud N, Morin D.

Sex Med. 2015 Mar;3(1):32-41. doi: 10.1002/sm2.50.


Endocrine management of male subfertility.

George B, Bantwal G.

Indian J Endocrinol Metab. 2013 Oct;17(Suppl 1):S32-4. doi: 10.4103/2230-8210.119500. Review.


Trial of recombinant follicle-stimulating hormone pretreatment for GnRH-induced fertility in patients with congenital hypogonadotropic hypogonadism.

Dwyer AA, Sykiotis GP, Hayes FJ, Boepple PA, Lee H, Loughlin KR, Dym M, Sluss PM, Crowley WF Jr, Pitteloud N.

J Clin Endocrinol Metab. 2013 Nov;98(11):E1790-5. doi: 10.1210/jc.2013-2518.


Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism.

Miraoui H, Dwyer AA, Sykiotis GP, Plummer L, Chung W, Feng B, Beenken A, Clarke J, Pers TH, Dworzynski P, Keefe K, Niedziela M, Raivio T, Crowley WF Jr, Seminara SB, Quinton R, Hughes VA, Kumanov P, Young J, Yialamas MA, Hall JE, Van Vliet G, Chanoine JP, Rubenstein J, Mohammadi M, Tsai PS, Sidis Y, Lage K, Pitteloud N.

Am J Hum Genet. 2013 May 2;92(5):725-43. doi: 10.1016/j.ajhg.2013.04.008.


Medical management of non-obstructive azoospermia.

Kumar R.

Clinics (Sao Paulo). 2013;68 Suppl 1:75-9. Review.


Medical therapy for spermatogenic failure.

Ramasamy R, Stahl PJ, Schlegel PN.

Asian J Androl. 2012 Jan;14(1):57-60. doi: 10.1038/aja.2011.63. Review.


Normosmic congenital hypogonadotropic hypogonadism due to TAC3/TACR3 mutations: characterization of neuroendocrine phenotypes and novel mutations.

Francou B, Bouligand J, Voican A, Amazit L, Trabado S, Fagart J, Meduri G, Brailly-Tabard S, Chanson P, Lecomte P, Guiochon-Mantel A, Young J.

PLoS One. 2011;6(10):e25614. doi: 10.1371/journal.pone.0025614.


The long-term clinical follow-up and natural history of men with adult-onset idiopathic hypogonadotropic hypogonadism.

Dwyer AA, Hayes FJ, Plummer L, Pitteloud N, Crowley WF Jr.

J Clin Endocrinol Metab. 2010 Sep;95(9):4235-43. doi: 10.1210/jc.2010-0245.


Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes.

Sykiotis GP, Hoang XH, Avbelj M, Hayes FJ, Thambundit A, Dwyer A, Au M, Plummer L, Crowley WF Jr, Pitteloud N.

J Clin Endocrinol Metab. 2010 Jun;95(6):3019-27. doi: 10.1210/jc.2009-2582.


Role of seminiferous tubular development in determining the FSH versus LH responsiveness to GnRH in early sexual maturation.

Pitteloud N, Thambundit A, Dwyer AA, Falardeau JL, Plummer L, Caronia LM, Hayes FJ, Lee H, Boepple PA, Crowley WF Jr.

Neuroendocrinology. 2009;90(3):260-8. doi: 10.1159/000245383.


GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism.

Chan YM, de Guillebon A, Lang-Muritano M, Plummer L, Cerrato F, Tsiaras S, Gaspert A, Lavoie HB, Wu CH, Crowley WF Jr, Amory JK, Pitteloud N, Seminara SB.

Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11703-8. doi: 10.1073/pnas.0903449106.


Indirect androgen doping by oestrogen blockade in sports.

Handelsman DJ.

Br J Pharmacol. 2008 Jun;154(3):598-605. doi: 10.1038/bjp.2008.150. Review.


Relative roles of inhibin B and sex steroids in the negative feedback regulation of follicle-stimulating hormone in men across the full spectrum of seminiferous epithelium function.

Boepple PA, Hayes FJ, Dwyer AA, Raivio T, Lee H, Crowley WF Jr, Pitteloud N.

J Clin Endocrinol Metab. 2008 May;93(5):1809-14. doi: 10.1210/jc.2007-2450.


Supplemental Content

Support Center